TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17699390

Group type: EXPERIMENTAL
Intervention: AA (Nutrineal 1.1%) plus G (Physioneal 1.36 to 3.86%)
Number of subjects: 12

Group type: COMPARATOR
Intervention: G only (control dialysate)
Number of subjects: 12
Study: 15126525

Group type: EXPERIMENTAL
Intervention: AndroGel (T gel) 1% CIII, 5, 7.5, or 10 g per day for up to 42 months
Number of subjects: 163
Study: 11483282

Group type: EXPERIMENTAL
Intervention: 2.5 microg recombinant HB vaccine
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: 5 microg recombinant HB vaccine
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: 10 microg recombinant HB vaccine
Number of subjects: 230
Study: 9494307

Group type: EXPERIMENTAL
Intervention: Ten-point numeric rating scale (NRS) for pain and discomfort rankings from 16 common procedures; N = 100
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Five-point numeric rating scale (NRS) for pain and discomfort rankings; N = 35
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Ten-point NRS reliability assessment with 30 additional subjects
Number of subjects: 135
Study: 8035392

Group type: EXPERIMENTAL
Intervention: Outpatient arthroscopic evaluation
Number of subjects: 33

Group type: COMPARATOR
Intervention: Plain radiographs
Number of subjects: 33

Group type: COMPARATOR
Intervention: MRI
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Arthroscopy
Number of subjects: 33
Study: 2590612

Group type: EXPERIMENTAL
Intervention: Aspirin 300 mg daily for 12 days
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Aspirin 300 mg daily for 12 days with ranitidine 150 mg 30 min before aspirin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control values (no aspirin)
Number of subjects: 30
Study: 4919119

Group type: EXPERIMENTAL
Intervention: Amantadine
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 31171470

Group type: EXPERIMENTAL
Intervention: Passive calf muscle stretching (ankle dorsiflexion applied 30 min/d, 5 days/wk) for 4 weeks
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (no muscle stretching for 4 weeks)
Number of subjects: 13
Study: 28165273

Group type: EXPERIMENTAL
Intervention: Brief telephone-based motivational counseling
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Brief telephone-based reduction counseling
Number of subjects: 347

Group type: COMPARATOR
Intervention: Active counseling (motivational and reduction)
Number of subjects: 347
Study: 24921209

Group type: EXPERIMENTAL
Intervention: Endocuff-assisted colonoscopy
Number of subjects: 498

Group type: COMPARATOR
Intervention: Standard colonoscopy
Number of subjects: 498
Study: 23821090

Group type: EXPERIMENTAL
Intervention: Screening with BNP testing (n=697)
Number of subjects: 1374

Group type: COMPARATOR
Intervention: Usual primary care (control condition; n=677)
Number of subjects: 1374
Study: 21401949

Group type: EXPERIMENTAL
Intervention: Acetaminophen (4 g/day) for 10 days in non-drinkers (Trial 1)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Acetaminophen (4 g/day) for 10 days in moderate drinkers (Trial 2)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Acetaminophen (4 g/day) for 5 days in chronic alcohol abusers (Trial 3)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Acetaminophen overdose (acute ingestion)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Non-acetaminophen hepatotoxin exposure
Number of subjects: 185
Study: 18671775

Group type: EXPERIMENTAL
Intervention: Probiotic fermented milk (Streptococcus thermophilus, Lactobacillus bulgaricus, Lactobacillus acidophilus, Bifidobacterium Longum)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Milk beverage containing no bacteria (placebo)
Number of subjects: 30
Study: 17436826

Group type: EXPERIMENTAL
Intervention: ER-minocycline 1 mg/kg daily
Number of subjects: 1038

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1038
Study: 12854893

Group type: EXPERIMENTAL
Intervention: Intrathecal (IT) chemotherapy via lumbar puncture (LP) for prophylaxis
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Intrathecal (IT) chemotherapy via lumbar puncture (LP) for treatment
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Systemic agents that cross the blood-brain barrier for prophylaxis
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Systemic agents that cross the blood-brain barrier for treatment
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: CNS surveillance and prophylaxis practices
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Willingness to participate in a randomized controlled trial (RCT)
Number of subjects: 49
Study: 10879804

Group type: EXPERIMENTAL
Intervention: Selenium supplementation
Number of subjects: 173

Group type: COMPARATOR
Intervention: Control (unsupplemented)
Number of subjects: 173
Study: 8707731

Group type: EXPERIMENTAL
Intervention: Teicoplanin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 0
Study: 1585840

Group type: EXPERIMENTAL
Intervention: Body Image Detection Device (BIDD) - BPI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Body Image Detection Device (BIDD) - SRI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Measures of weight dissatisfaction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (psychiatric)
Number of subjects: 0
Study: 6086435

Group type: EXPERIMENTAL
Intervention: Marijuana cigarettes with high delta 9-THC concentration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo marijuana cigarette
Number of subjects: 0
Study: 31581920

Group type: EXPERIMENTAL
Intervention: 3-minute Step Test (3MStepT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 6-minute Walk Test (6MWT)
Number of subjects: 50
Study: 29741665

Group type: EXPERIMENTAL
Intervention: Eligibility criteria predicting STI diagnoses
Number of subjects: 1774

Group type: COMPARATOR
Intervention: Participants enrolled outside eligibility criteria
Number of subjects: 1774
Study: 27597866

Group type: EXPERIMENTAL
Intervention: Piezosurgery
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional bur technique
Number of subjects: 20
Study: 24886272

Group type: EXPERIMENTAL
Intervention: Spironolactone 25 mg once daily for 40 weeks
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo (inactive)
Number of subjects: 240
Study: 22324460

Group type: EXPERIMENTAL
Intervention: NiTiR technique (after education)
Number of subjects: 850

Group type: COMPARATOR
Intervention: Stainless steel hand instrumentation (before education)
Number of subjects: 850
Study: 21492636

Group type: COMPARATOR
Intervention: ICP/CPP management only (Group A)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: ICP/CPP guided with mild hypothermia (Group B)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combined mild hypothermia and P(ti)o(2) guided with CPP management (Group C)
Number of subjects: 45
Study: 18555911

Group type: EXPERIMENTAL
Intervention: Nurse-coordinated multidisciplinary, family-based preventive cardiology programme (INT)
Number of subjects: 1589
Study: 16229368

Group type: EXPERIMENTAL
Intervention: Radiation therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hormone therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment method
Number of subjects: 0
Study: 12201326

Group type: EXPERIMENTAL
Intervention: 20 μg ethinylestradiol (EE) + 100 μg levonorgestrel (LNG)
Number of subjects: 18
Study: 10030555

Group type: EXPERIMENTAL
Intervention: Topical indomethacin 0.1% solution
Number of subjects: 50

Group type: COMPARATOR
Intervention: Topical dexamethasone phosphate 0.1% solution
Number of subjects: 50
Study: 7573865

Group type: EXPERIMENTAL
Intervention: 2% halothane
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.5% halothane
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1% enflurane
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.5% halothane (longer duration)
Number of subjects: 60
Study: 2037853

Group type: EXPERIMENTAL
Intervention: Active negative pressure ventilation
Number of subjects: 184

Group type: COMPARATOR
Intervention: Sham negative pressure ventilation
Number of subjects: 184
Study: 7010995

Group type: EXPERIMENTAL
Intervention: Somatropin (0.1 IU/kg in three doses per week)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Somatropin (0.1 IU/kg in three doses per week) + Oxandrolone (0.1 mg/kg/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (Somatropin alone)
Number of subjects: 12
Study: 31435774

Group type: EXPERIMENTAL
Intervention: Gabapentin 300 mg three times daily initially (900 mg), with 300 mg weekly incremental dose till pain was controlled, maximum daily dose of 2700 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 28323503

Group type: EXPERIMENTAL
Intervention: ALO 25 mg QD
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ALO 25 mg QD and PIO 30 mg QD
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both ALO and ALO-PI
Number of subjects: 30
Study: 25743855

Group type: EXPERIMENTAL
Intervention: Aprepitant + Dexamethasone (A + D)
Number of subjects: 303

Group type: COMPARATOR
Intervention: Metoclopramide + Dexamethasone (M + D)
Number of subjects: 303
Study: 23472765

Group type: EXPERIMENTAL
Intervention: Trophic enteral feedings (15 mL/kg/d) during indomethacin or ibuprofen treatment (n = 81)
Number of subjects: 177

Group type: COMPARATOR
Intervention: No feeds (fasting [nil per os] group) during indomethacin or ibuprofen treatment (n = 96)
Number of subjects: 177
Study: 21214369

Group type: EXPERIMENTAL
Intervention: Low intensity laser therapy (LILT) using a 630 nm diode laser
Number of subjects: 30

Group type: COMPARATOR
Intervention: Topical corticosteroids (Dexamethason mouth wash)
Number of subjects: 30
Study: 19391533

Group type: EXPERIMENTAL
Intervention: Pecking moxibustion therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Common acupuncture
Number of subjects: 50
Study: 17051872

Group type: EXPERIMENTAL
Intervention: Active ionic toothbrush (equipped with lithium battery)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Inactive ionic toothbrush (without lithium battery)
Number of subjects: 20
Study: 12772004

Group type: EXPERIMENTAL
Intervention: Pantoprazole
Number of subjects: 221

Group type: COMPARATOR
Intervention: Nizatidine
Number of subjects: 221
Study: 11262983

Group type: EXPERIMENTAL
Intervention: Nimesulide (1.5 mg/kg/dose)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Paracetamol (10.0 mg/kg/dose)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Ibuprofen-paracetamol combination (10.0 mg/kg/dose)
Number of subjects: 89
Study: 9091331

Group type: EXPERIMENTAL
Intervention: GnRH‐a plus OC
Number of subjects: 30

Group type: COMPARATOR
Intervention: OC alone
Number of subjects: 30
Study: 8392581

Group type: EXPERIMENTAL
Intervention: High power density (HPD) laser treatment (60 W, spot size 1-1.5 mm)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Low power density (LPD) laser treatment (20 W, spot size 1-1.5 mm)
Number of subjects: 204
Study: 3549473

Group type: EXPERIMENTAL
Intervention: ranitidine 150 mg bd
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: sucralfate 1 g qid
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: NSAIDs continued during treatment
Number of subjects: 67

Group type: COMPARATOR
Intervention: NSAIDs stopped during treatment
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: 12 month follow up
Number of subjects: 67
Study: 31297799

Group type: EXPERIMENTAL
Intervention: Divergent Thinking exercises without examples
Number of subjects: 120

Group type: COMPARATOR
Intervention: Divergent Thinking exercises with examples
Number of subjects: 120

Group type: COMPARATOR
Intervention: Neutral control exercises
Number of subjects: 120
Study: 30587217

Group type: EXPERIMENTAL
Intervention: Mindfulness-based group psychotherapy ("Mind it!") in addition to existing treatment regime
Number of subjects: 340

Group type: COMPARATOR
Intervention: Current standard treatment
Number of subjects: 340
Study: 27966023

Group type: EXPERIMENTAL
Intervention: Bismuth
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 24718082

Group type: EXPERIMENTAL
Intervention: Intensive intervention (n = 38)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Minimal intervention (n = 40)
Number of subjects: 80
Study: 23972294

Group type: EXPERIMENTAL
Intervention: 7 mm Hg
Number of subjects: 171

Group type: COMPARATOR
Intervention: 20 mm Hg
Number of subjects: 171
Study: 19955694

Group type: EXPERIMENTAL
Intervention: Class Ia antiarrhythmic agents
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Class Ib antiarrhythmic agents
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Class Ic antiarrhythmic agents
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Class III antiarrhythmic agents
Number of subjects: 419
Study: 18398154

Group type: EXPERIMENTAL
Intervention: bexarotene 400 mg/m(2)/d with cisplatin/vinorelbine
Number of subjects: 623

Group type: COMPARATOR
Intervention: cisplatin/vinorelbine alone
Number of subjects: 623
Study: 17114152

Group type: EXPERIMENTAL
Intervention: Real rTMS (100% of resting motor threshold, 30 pulses at 10 Hz for 5 min)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham TMS (audio recording of actual TMS stimulus sounds)
Number of subjects: 15
Study: 15125904

Group type: EXPERIMENTAL
Intervention: Montelukast (Singulair) 10 mg daily for two menstrual cycles
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo for two menstrual cycles
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Ibuprofen (200 mg tablets) as needed
Number of subjects: 25
Study: 11515643

Group type: EXPERIMENTAL
Intervention: Oral health care education (OHCE) for nursing home caregivers
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no OHCE)
Number of subjects: 22
Study: 9763500

Group type: EXPERIMENTAL
Intervention: Combined hepatitis A-hepatitis B vaccine administered at 0, 1, and 6 months
Number of subjects: 160
Study: 7816991

Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol (200 micrograms)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 3144686

Group type: EXPERIMENTAL
Intervention: Penicillin V
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Erythromycin (base)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Erythromycin (stearate)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Placebo (previous study)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Erythromycin (overall)
Number of subjects: 195
Study: 28631050

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion rate titrated to keep ANI monitoring values between 50–70 (Group ANI, n: 22)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Remifentanil infusion rate regulated according to hemodynamic parameters (Group control, n: 22)
Number of subjects: 44
Study: 28475555

Group type: COMPARATOR
Intervention: Epidural bupivacaine with 2 μg/ml fentanyl
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine with 2 μg/ml neostigmine
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine with 4 μg/ml neostigmine
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine with 8 μg/ml neostigmine
Number of subjects: 215
Study: 25602863

Group type: EXPERIMENTAL
Intervention: Minimal intervention consisting of 3 mailings and 1 coaching call
Number of subjects: 498

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 498
Study: 23664565

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 50
Study: 21364505

Group type: COMPARATOR
Intervention: Propofol with saline (control group)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Propofol with 2.5 ng mL(‐1) of remifentanil (low‐remifentanil group)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Propofol with 5.0 ng mL(‐1) of remifentanil (high‐remifentanil group)
Number of subjects: 67
Study: 18482661

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day
Number of subjects: 10001

Group type: COMPARATOR
Intervention: Atorvastatin 10 mg/day
Number of subjects: 10001
Study: 16488434

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine continuous infusion for 120 hours
Number of subjects: 27

Group type: COMPARATOR
Intervention: 0.9% saline solution continuous infusion for 120 hours
Number of subjects: 27

Group type: COMPARATOR
Intervention: Standard axillary lymph node dissection
Number of subjects: 27
Study: 14515673

Group type: EXPERIMENTAL
Intervention: Participative educational intervention (EG)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Traditional educational intervention (CG)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Comparison of both groups after interventions
Number of subjects: 2
Study: 10881620

Group type: EXPERIMENTAL
Intervention: Random-practice
Number of subjects: 2

Group type: COMPARATOR
Intervention: Blocked-practice
Number of subjects: 2
Study: 9120459

Group type: EXPERIMENTAL
Intervention: Immunoprecipitation of (125)I‐glutamic acid decarboxylase
Number of subjects: 18
Study: 8409313

Group type: EXPERIMENTAL
Intervention: Dichotomous listening (DL) to induce stress
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-DL control test
Number of subjects: 20
Study: 3530032

Group type: EXPERIMENTAL
Intervention: Sustained-release terbutaline 7.5 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 28737261

Group type: EXPERIMENTAL
Intervention: Integrative cognitive‐behavioural therapy for PGD (PG‐CBT)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 51
Study: 27707827

Group type: EXPERIMENTAL
Intervention: Spironolactone (25 mg daily for 2 years)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo (matched, for 2 years)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study: 24680148

Group type: EXPERIMENTAL
Intervention: Transvaginal endoscopic surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Laparoscopic approach (control)
Number of subjects: 40
Study: 22856254

Group type: EXPERIMENTAL
Intervention: Wool underwear (treatment group)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 48
Study: 21189769

Group type: EXPERIMENTAL
Intervention: Carisolv system
Number of subjects: 40

Group type: COMPARATOR
Intervention: 10% sodium hypochlorite gel
Number of subjects: 40
Study: 17140704

Group type: EXPERIMENTAL
Intervention: Frontotemporal dementia patients
Number of subjects: 132

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 132
Study: 15955465

Group type: EXPERIMENTAL
Intervention: Step‐One‐Diet plus glucomannan in gelatine capsules
Number of subjects: 40

Group type: COMPARATOR
Intervention: Step‐One‐Diet only (control)
Number of subjects: 40
Study: 14610118

Group type: EXPERIMENTAL
Intervention: Plasma Aβ42 levels in patients with AD at baseline and those who developed AD during follow-up
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Plasma Aβ42 levels in the highest quartile
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Plasma Aβ42 levels in patients with AD who died during follow-up
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Plasma Aβ42 levels in patients with newly acquired AD
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Plasma Aβ40 levels
Number of subjects: 530
Study: 10390735

Group type: EXPERIMENTAL
Intervention: Avoidant coping
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Quality of life
Number of subjects: 61
Study: 8558225

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 179

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 179
Study: 1910798

Group type: COMPARATOR
Intervention: Ephedrine (10 mg IV bolus injections)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Phenylephrine (80 microgram IV bolus injections)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 60
Study: 7034927

Group type: EXPERIMENTAL
Intervention: 2400‐rad craniospinal RT plus 1200‐rad extended‐field RT
Number of subjects: 724

Group type: EXPERIMENTAL
Intervention: 2400‐rad craniospinal RT
Number of subjects: 724

Group type: EXPERIMENTAL
Intervention: 2400‐rad cranial RT plus i.t. MTX
Number of subjects: 724

Group type: COMPARATOR
Intervention: i.t. MTX alone
Number of subjects: 724

Group type: EXPERIMENTAL
Intervention: Cranial RT plus i.t. MTX
Number of subjects: 724

Group type: EXPERIMENTAL
Intervention: Overall study
Number of subjects: 724
Study: 31887309

Group type: EXPERIMENTAL
Intervention: linagliptin 5 mg + metformin 1700 mg daily + lifestyle
Number of subjects: 144

Group type: COMPARATOR
Intervention: metformin 1700 mg daily + lifestyle
Number of subjects: 144
Study: 29112512

Group type: EXPERIMENTAL
Intervention: High-quality SSC implementation
Number of subjects: 3702

Group type: EXPERIMENTAL
Intervention: Forced air warming blankets
Number of subjects: 3702

Group type: EXPERIMENTAL
Intervention: Antibiotic administration postincision
Number of subjects: 3702

Group type: EXPERIMENTAL
Intervention: Antibiotic administration preincision
Number of subjects: 3702

Group type: EXPERIMENTAL
Intervention: Nonadministration of antibiotics
Number of subjects: 3702

Group type: EXPERIMENTAL
Intervention: Surgical infections
Number of subjects: 3702

Group type: EXPERIMENTAL
Intervention: SSC effect on surgical infections
Number of subjects: 3702

Group type: EXPERIMENTAL
Intervention: Antibiotics provided before incision
Number of subjects: 3702

Group type: EXPERIMENTAL
Intervention: SSC implementation
Number of subjects: 3702
Study: 29856288

Group type: EXPERIMENTAL
Intervention: Low-dose ketamine
Number of subjects: 0
Study: 27800705

Group type: EXPERIMENTAL
Intervention: Home-based HIV counseling and testing (HBHCT) by lay counselors
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: Quality of pre-test and post-test counseling sessions
Number of subjects: 406
Study: 23813190

Group type: EXPERIMENTAL
Intervention: Head camera visual analysis during naming events
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Learned object names
Number of subjects: 0
Study: 22452536

Group type: EXPERIMENTAL
Intervention: 10 ml reciprocating procedure device (RPD) mechanical syringe
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 60 ml vacuum syringe
Number of subjects: 10
Study: 19890774

Group type: EXPERIMENTAL
Intervention: Venlafaxine extended release (dosage not specified)
Number of subjects: 8506